Summary
- Current Price
- As of today, CATX price is $2.57, down -6.88% on
- Current Price All-Time High
- CATX price is currently -96.98% below its historical high of $85.00 set on
- Market Cap
- CATX current market cap is $293M, up +11.17% over the past 365 days
- Revenue
- CATX current annual revenue is $884.00K, down -39.20% year-over-year
- Next Earnings
- The next earnings release for CATX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Perspective Therapeutics, Inc. |
| Ticker | NYSEAmerican: CATX |
| Exchange | NYSE American |
| Sector | Healthcare |
| Industry | Medical Devices |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | perspectivetherapeutics.com |
| Employees | 138 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $2.57 | ||
| Price, 1D Change | -6.88% | |
| $293M | ||
| - | ||
| - | ||
| 0.93 | ||
| $884.00K | ||
| Revenue, 1Y Change | -39.20% | |
| -$1.40 | ||
| EPS, 1Y Change | -13.53% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | ISR | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| -$1.40 | ||
| EPS Estimate | -$0.98 | N/A |
| EPS Est. Change | +29.52% | N/A |
| $884.00K | ||
| Revenue Estimate | $297.21K | N/A |
| Revenue Est. Change | -66.38% | N/A |
| $2.57 | ||
| Price Target | $13.00 | - |
| Price Tgt. Change | +405.84% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | N/A | - | |
| -$1.20 | -$1.40 | -16.80% | |
| -$0.98 | N/A | +29.52% | |
| -$1.02 | N/A | +26.71% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $11.18M | N/A | +668.91% | |
| $1.07M | $884.00K | -17.46% | |
| $297.21K | N/A | -66.38% | |
| $365.71K | N/A | -58.63% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -27.61% | ||
| -14.33% | ||
| +11.17% | ||
| +248.54% | ||
| -39.20% | ||
| -38.35% | ||
| -13.53% | ||
| +19.60% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $2.57 | ||
| $3.61 | ||
| $2.97 | ||
| $3.41 | ||
| $2.94 | ||
| -$0.11 | ||
| 0.93 | ||
| $0.19 | ||
| 39.85 | ||
| 81.19% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $884.00K | ||
| -$1.40 | ||
| -$2.37M | ||
| -267.76% | ||
| -$103.56M | ||
| -11.72% | ||
| -$103.64M | ||
| -11.72% | ||
| -$100.31M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.02 | ||
| 5.17 | ||
| 5.17 | ||
| - | ||
| 1 | ||
| 0.19 |
Valuations
| Metric | Value | Date |
|---|---|---|
| - | ||
| 717.29 | ||
| 0.91 | ||
| -0.54 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $207.03M | ||
| $144.74M | ||
| $274.35M | ||
| $148.39M | ||
| $67.31M | ||
| $28.68M | ||
| $3.25M | ||
| $679.00K | ||
| $20.51M |
Expenses
| Metric | Value | Date |
|---|---|---|
| $104.52M | ||
| $101.20M | ||
| $3.25M | ||
| $0.00 | ||
| $3.25M | ||
| $0.00 | ||
| -$793.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$82.48M | ||
| $41.23M | ||
| $10.31M | ||
| $12.88M | ||
| -$95.37M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| William Blair | ||
| Wedbush | → | |
| BMO Capital | ||
| B of A Securities | → | |
| Piper Sandler | → | |
| Wedbush | → | |
| BTIG | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| Wedbush | → |
Analyst sentiment
Institutional ownership
No data
Screeners with CATX
FAQ
- What is the ticker symbol for Perspective Therapeutics, Inc.?
- The ticker symbol for Perspective Therapeutics, Inc. is NYSEAmerican:CATX
- Does Perspective Therapeutics, Inc. pay dividends?
- No, Perspective Therapeutics, Inc. does not pay dividends
- What sector is Perspective Therapeutics, Inc. in?
- Perspective Therapeutics, Inc. is in the Healthcare sector
- What industry is Perspective Therapeutics, Inc. in?
- Perspective Therapeutics, Inc. is in the Medical Devices industry
- What country is Perspective Therapeutics, Inc. based in?
- Perspective Therapeutics, Inc. is headquartered in United States
- When did Perspective Therapeutics, Inc. go public?
- Perspective Therapeutics, Inc. initial public offering (IPO) was on November 10, 2005
- Is Perspective Therapeutics, Inc. in the S&P 500?
- No, Perspective Therapeutics, Inc. is not included in the S&P 500 index
- Is Perspective Therapeutics, Inc. in the NASDAQ 100?
- No, Perspective Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Perspective Therapeutics, Inc. in the Dow Jones?
- No, Perspective Therapeutics, Inc. is not included in the Dow Jones index
- When was Perspective Therapeutics, Inc. last earnings report?
- Perspective Therapeutics, Inc.'s most recent earnings report was on August 10, 2026
- When does Perspective Therapeutics, Inc. report earnings?
- The next expected earnings date for Perspective Therapeutics, Inc. is November 9, 2026
Data Sources & References
- CATX Official Website www.perspectivetherapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/728387/000072838726000004/0000728387-26-000004-index.htm
- CATX Profile on Yahoo Finance finance.yahoo.com/quote/CATX
- CATX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/catx